Novartis maps $100M R&D complex in China
Novartis is building a $100 million research center in Shanghai, another example of the growing clout that China is demonstrating in the drug development industry. The 400,000-square-foot center will be Novartis' eighth R&D complex, employing some 400 scientists. Construction is set to begin the middle of next year. Analysts said that Novartis was lining up to take advantage of a lower-cost approach to developing new therapies.
- here's the AFP report on Novartis' China plans
Related Articles:
Novartis to build $600M flu plant in N.C. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
